Zavegepant: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Zavegepant. Educational only — not medical advice.
Labeled uses
ZAVZPRET is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use ZAVZPRET is not indicated for the preventive treatment of migraine.
Source: FDA labeling via NIH DailyMed (set 9c4a7aec…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.